Eli Lilly said clinical results of its GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable ...

The drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...

Eli Lilly (LLY) announced on Thursday that its weight loss pill has succeeded Phase 3 trials on Type 2 diabetes patients, ...

This will differentiate it from weight-loss jabs, known medically as glucagon-like peptide-1 receptor agonists, which are currently only approved for obese patients. And rather than compete ...

Medically reviewed by Allison Herries, RDN Losing excess body fat can improve physical and mental health, but reaching your ...

Many people living with type 2 diabetes can manage their blood glucose levels with lifestyle changes and oral medication. However, if these treatments don’t help control glucose levels ...

The study investigates an emerging research field: the interaction between sleep and development. The authors use Drosophila larvae sleep as a study model and provide valuable insight into how ...

A study has been conducted to evaluate the effectiveness of the GLP-1 Formula (product name: Slim8D No. 2) in weight reduction and its potential as an obesity treatment. The research found that "the ...